ID: ALA5287954

Max Phase: Preclinical

Molecular Formula: C32H28FNO8

Molecular Weight: 573.57

Associated Items:

Representations

Canonical SMILES:  COc1cc([C@@H]2Oc3cc(/C=C/c4cc(O)cc(O)c4)ccc3O[C@H]2CNC(=O)c2ccc(F)cc2)cc(OC)c1O

Standard InChI:  InChI=1S/C32H28FNO8/c1-39-27-14-21(15-28(40-2)30(27)37)31-29(17-34-32(38)20-6-8-22(33)9-7-20)41-25-10-5-18(13-26(25)42-31)3-4-19-11-23(35)16-24(36)12-19/h3-16,29,31,35-37H,17H2,1-2H3,(H,34,38)/b4-3+/t29-,31-/m0/s1

Standard InChI Key:  AJGOMIPHYFCYMW-QPJPOZQVSA-N

Associated Targets(Human)

HT-29 (80576 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HCT-116 (91556 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 573.57Molecular Weight (Monoisotopic): 573.1799AlogP: 5.44#Rotatable Bonds: 8
Polar Surface Area: 126.71Molecular Species: NEUTRALHBA: 8HBD: 4
#RO5 Violations: 2HBA (Lipinski): 9HBD (Lipinski): 4#RO5 Violations (Lipinski): 2
CX Acidic pKa: 8.57CX Basic pKa: CX LogP: 5.46CX LogD: 5.43
Aromatic Rings: 4Heavy Atoms: 42QED Weighted: 0.21Np Likeness Score: 0.43

References

1. Yao L, Cai W, Chen S, Wang A, Wang X, Zhao C, Shou C, Jia Y..  (2023)  Design, syntheses and biological evaluation of natural product aiphanol derivatives and analogues: Discovery of potent anticancer agents.,  90  [PMID:37182611] [10.1016/j.bmcl.2023.129326]

Source